2.85Open2.85Pre Close0 Volume1 Open Interest67.00Strike Price0.00Turnover2813.39%IV-4.09%PremiumNov 22, 2024Expiry Date5.83Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9413Delta0.0301Gamma12.45Leverage Ratio-166.2915Theta0.0000Rho11.72Eff Leverage0.0002Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet